Glaxo HPV vaccine protects women from anal cancer
August 23, 2011 — CHICAGO (Reuters) - A vaccine to prevent cervical cancer offered strong protection against anal cancer in a large study of women in Costa Rica, adding to evidence that such vaccines can protect against more than just cervical cancer, U.S. researchers said on Monday.
Glaxo HPV vaccine protects women from anal cancer
August 23, 2011 — CHICAGO (Reuters) - A vaccine to prevent cervical cancer offered strong protection against anal cancer in a large study of women in Costa Rica, adding to evidence that such vaccines can protect against more than just cervical cancer, U.S. researchers said on Monday.
Half of men may have HPV infections: study
March 1, 2011 — CHICAGO (Reuters) - Half of men in the general population may be infected with human papillomavirus or HPV, the human wart virus that causes cervical and other cancers, strengthening the case for vaccinating boys against HPV, U.S. researchers said on Monday.
Select news items provided by Reuters Health